ANDA Litigation Settlements

Case Name Drug Patent No(s). Publicly Available Terms

Boehringer Ingelheim Pharma GMBH v. Amneal Pharms. LLC, 14-4726 (D.N.J.)

Aggrenox® (dipyridamole extended-release tablets)


Settlement releases all claims,
counterclaims, and affirmative defenses, and will remain in effect until the expiration of the patent-in-suit on Jan. 18, 2017.

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.